Neuropharmacology

Rapid Turnaround PK/PD Screening Programs for your CNS Drug Candidates - February, 2014

Achieving successful drug delivery and understanding the relevant pharmacodynamics represent prominent challenges in CNS drug development. Despite the availability of several in vitro models, animal models still represent the most effective option for quickly assessing the pharmacokinetic (PK) and -dynamic (PD) properties of biologically active compounds.

QPS offers a selection of transgenic models, a wide variety of administration routes and sampling techniques, and state-of-the-art bioanalytical laboratories for cost-efficient and rapid-turnaround in-vivo screening of your CNS lead compounds.

Please learn more about QPS rapid turnaround PK/PD screening programs for CNS drug candidates.

back
top
20 years in pharma R&D navigation